MRNA
$207.97+4.59%
as of close, Oct 27, 2026
☾ AH $207.97 +4.59%
Moderna Inc. total returns by year (including dividends)
As of market close, Oct 27, 2026
Moderna Inc. total returns by year (2019–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $29.49 | $207.97 | 0.0% | +605.2% | |
| 2025 | $41.58 | $29.49 | 0.0% | -29.1% | |
| 2024 | $99.45 | $41.58 | 0.0% | -58.2% | |
| 2023 | $179.62 | $99.45 | 0.0% | -44.6% | |
| 2022 | $253.98 | $179.62 | 0.0% | -29.3% | |
| 2021 | $104.47 | $253.98 | 0.0% | +143.1% | |
| 2020 | $19.56 | $104.47 | 0.0% | +434.1% | |
| 2019 | $15.27 | $19.56 | 0.0% | +28.1% |
- Annualized
- +39.6%
- 2019–2026
- Average year
- +63.4%
- 7 full years
- Best year
- +434.1%
- 2020
- Worst year
- -58.2%
- 2024
- Positive years
- 3/7
- 43% up
Annualized (CAGR)
+39.6%
2019–2026
Average year
+63.4%
7 full years
Best year
+434.1%
2020
Worst year
-58.2%
2024
Positive years
3/7
43% up
Total return by period#
Annual
-600%-400%-200%0%200%400%600%
2019+28%'19
2020+434%'20
2021+143%'21
2022-29%'22
2023-45%'23
2024-58%'24
2025-29%'25
2026+605%'26
Methodology#
Total returns, dividends reinvested, measured on MRNA. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Moderna Inc.'s average annual return?
- Since 2019, Moderna Inc. (MRNA) has returned about 39.6% a year (the compound annual growth rate) and an average calendar-year return of 63.4%.
- What were Moderna Inc.'s best and worst years?
- Over 2019–2026, the best year was 2020 (+434.1%) and the worst was 2024 (-58.2%).
- How often is Moderna Inc. up in a year?
- 3 of the 7 full years since 2019 were positive — about 43% of the time.
More on Moderna Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100